Pnc Financial Services Group, Inc. Agenus Inc Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.53 - $0.93 $542 - $952	1,024 Added 211.57%	1,508 $0
Q4 2023 Feb 09, 2024	BUY	$0.63 - $1.14 $304 - $551	484 New	484 $0
Q2 2019 Aug 09, 2019	SELL	$2.53 - $3.04 $2,497 - $3,000	-987 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$1.59 - $2.42 $615 - $936	387 Added 64.5%	987 $0
Q4 2017 Feb 09, 2018	SELL	$3.26 - $4.78 $33,904 - $49,712	-10,400 Reduced 94.55%	600 $0
Q3 2017 Nov 13, 2017	BUY	$3.48 - $4.44 $38,280 - $48,840	11,000	11,000 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.